Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
13.00
+2.21 (20.48%)
At close: Jun 12, 2026, 4:00 PM EDT
12.99
-0.01 (-0.08%)
After-hours: Jun 12, 2026, 7:44 PM EDT

Sensei Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1713121746178
Market Cap Growth
134.59%9.12%-28.77%-62.22%-74.18%-
Enterprise Value
-184.31-6.21-25.15-42.23-53.2432.27
Last Close Price
13.0010.679.8013.8429.80116.00
PB Ratio
-0.720.320.270.441.21
EV/EBITDA Ratio
-0.280.781.161.07-
EV/EBIT Ratio
-0.280.771.141.06-
EV/FCF Ratio
-0.301.011.311.35-
Debt / Equity Ratio
-0.000.040.060.060.01
Net Debt / Equity Ratio
1.47-1.06-0.98-0.92-0.96-0.99
Net Debt / EBITDA Ratio
1.090.891.171.632.003.95
Net Debt / FCF Ratio
8.370.961.511.852.524.50
Quick Ratio
14.294.987.5911.6511.8230.19
Current Ratio
14.395.067.7011.9211.9830.38
Return on Equity (ROE)
310.81%-74.01%-58.40%-40.52%-38.88%-81.70%
Return on Assets (ROA)
-162.64%-65.30%-54.48%-38.46%-36.96%-42.92%
Return on Invested Capital (ROIC)
-7376.95%-518.63%-425.96%-345.10%-580.88%-1111.07%
Return on Capital Employed (ROCE)
-176.93%-76.11%-60.04%-41.64%-38.96%-45.45%
Buyback Yield / Dilution
-0.96%-0.40%10.15%8.96%-10.80%-1618.87%
Total Shareholder Return
-0.96%-0.40%10.15%8.96%-10.80%-1618.87%
SEC Filings: 10-K · 10-Q